MOUNTAIN VIEW, Calif., Oct. 5 /PRNewswire-FirstCall/ -- Omnicell, Inc ., (Nasdaq: OMCL ) a leading provider of medication management solutions to acute healthcare facilities, today announced the acquisition of Pandora Data Systems , a leading provider of analytical software for medication diversion detection and regulatory compliance. The two companies will combine their expertise in medication analytics to enhance diversion detection and clinical benchmarking that helps to ensure regulatory compliance.
"We believe the two companies' complementary, best-in-class products and technologies will be of great value to all of our customers," said Jim Felich, CEO of Pandora Data Systems. "Our partnership with the Omnicell team will allow us to continue our commitment to patient safety and help hospital systems meet the increasingly stringent requirements of the DEA and The Joint Commission."
The Pandora Data Systems solution will continue to operate as a stand-alone product, producing reports for CareFusion, McKesson, Cerner and other medication management systems, and providing regular updates and releases for its customer base.
Pandora will leverage the Omnicell development expertise to provide best-in-class analytics for drug diversion detection, compliance reporting and long term data storage. Its customers will also benefit from Omnicell's infrastructure for expanded service and support.
"I am thrilled to welcome the Pandora employees and customers to the Omnicell family, as together, we commit to the universal improvement of healthcare," said Randall Lipps, CEO of Omn